CLINICAL TRIALS PROFILE FOR SYMLIN
✉ Email this page to a colleague
All Clinical Trials for Symlin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00189514 ↗ | A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects | Completed | AstraZeneca | Phase 2 | 2005-09-01 | This is a long term extension to study 137OB-201 which is designed to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects. |
NCT00229658 ↗ | An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes | Completed | AstraZeneca | 2005-09-01 | This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy. | |
NCT00240253 ↗ | A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes | Completed | AstraZeneca | Phase 4 | 2005-10-01 | The purpose of this study is to evaluate the efficacy and safety of adding Symlin to an established regimen of insulin glargine in subjects with type 2 diabetes who are not achieving glycemic targets. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Symlin
Condition Name
Clinical Trial Locations for Symlin
Trials by Country
Clinical Trial Progress for Symlin
Clinical Trial Phase
Clinical Trial Sponsors for Symlin
Sponsor Name